Jane Osbourn, Alchemab

"Don't be afraid to just try something. The worst thing you can do in Biotech is not make a decision. There are lots of right decisions, there are some wrong ones, but there's a point at which just doing something and seeing what happens is how you learn and make progress." Jane Osbourn is a genuine world leader in the discovery and development of antibody therapeutics. Currently Chief Scientific Officer of Alchemab Therapeutics and Chair at Mogrify, Jane has also served as Chair of the BioIndustry Association, is a Director of Cambridge Enterprise and in 2019, she was awarded an OBE for services to science and the drug research industry as well as the Scrip's Lifetime Achievement Award for contribution to biopharma. Jane joined us on Careers in Discovery to share her journey, her advice and her views on careers, science, Biotech and more. Enjoy!